supported by the Key Fund for Developing New Drugs from the Ministry of Science and Technology of China(2014ZX09101005-005);the National Natural Science Foundation of China(81071019);the National Key Basic Research Program of China(2011CBA00400);the Natural Science Foundation of Shanghai Municipality,China(13JC1401500);the Fund for Medical Emerging Cutting-Edge Technology in Shanghai of China (SHDC12012114)
Abstract To date, we still lack disease-modifying thera- pies for Alzheimer's disease (AD). Here, we report that long-term administration of benfotiamine improved the cognitive ability of patients with AD. Five pat...
supported by grants from the National Natural Science Foundation of China(81071019);the International Cooperation Foundation of Shanghai Municipality, China (10430709600);the Outstanding Academic Leaders Foundation in Shanghai, China(11XD1401500)
Objective To determine whether high glucose enhances β-amyloid (Aβ) production in HEK293 Swedish mutant (APPsw) cells with Aβ precursor protein (APP) overexpression, and whether under this condition benfotiam...